QUANTUM GENOM NR Share Price Euronext Paris
Equities
FR0010783837
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- EUR | - |
|
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 7.74M 8.39M 700M |
---|---|---|---|---|---|
Net income 2024 * | -3M -3.25M -271M | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | 8.7M 9.43M 787M | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.23
x | P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.23% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | - | |
Lionel Ségard
FOU | Founder | 56 | 23/05/23 |
Benoît Gueugnon
DFI | Director of Finance/CFO | - | 01/18/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lionel Ségard
FOU | Founder | 56 | 23/05/23 |
François Pelen
BRD | Director/Board Member | 67 | - |
Chief Executive Officer | 63 | - |
1st Jan change | Capi. | |
---|---|---|
+18.97% | 45.34B | |
+41.98% | 40.42B | |
-10.06% | 37.92B | |
+31.15% | 31.75B | |
-7.79% | 27.71B | |
+13.32% | 26.52B | |
+43.05% | 13.96B | |
+31.28% | 12.44B | |
-7.41% | 11.26B |